Medicare Part B Payment for COVID-19 Vaccines and Certain Monoclonal Antibodies during the Public Health Emergency

CMS has released a set of toolkits for providers, states, and insurers to help the health care system get ready to swiftly administer the COVID-19 vaccines and certain monoclonal antibodies once they become available. The resources are designed to increase the number of providers that can administer the products and ensure adequate Medicare reimbursement for the administration. To know the payment allowances and other related information for these products, keep reading!